Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06284122 |
| Title | Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 (MorningLyte) |
| Acronym | MorningLyte |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | The Lymphoma Academic Research Organisation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA | ESP | DEU | BEL |